Investigation Report on China’s Enteral Nutrition Market 2021-2025

$2,600$3,900

In 2020, due to the impact of the COVID-19 epidemic on the hospital’s overall diagnosis and treatment services, the sales value of Enteral Nutrition in China fell slightly, reached CNY1.155 billion in 2020.

Clear

Description

Enteral nutrition is mainly used for preoperative feeding of patients with anorexia and related diseases, including mechanical gastrointestinal dysfunction, critical illness, and malnutrition. It was developed by Fresenius Kabi and was in China in 1995. Chinese market. By 2020, in addition to Niudi Xiya Pharmaceutical (Wuxi) Co.,Ltd., there are Fresenius Kabi Deutschland GmbH, Fresenius Kabi Huarui Pharmaceutical Co., Ltd., Abbott Laboratories BV, and Milupa GmnH & Co KG and other 8 manufacturers in China’s Enteral Nutrition market.

According to CRI analysis, the sales value of Enteral Nutrition in China has grown steadily year by year from 2016 to 2019. In 2020, due to the impact of the COVID-19 epidemic on the hospital’s overall diagnosis and treatment services, the sales value of Enteral Nutrition in China fell slightly, reached CNY1.155 billion in 2020. The CAGR of the sales value of Enteral Nutrition is about 6.5% from 2016 to 2020 in China.

CRI expects that with the effective relief of the COVID-19 epidemic, the sales of Enteral Nutrition in the Chinese market will have a restorative growth from 2021 to 2025. In addition, Enteral Nutrition is widely used clinically. With the improvement and popularization of medical services in China, the demand for Enteral Nutrition will continue to increase, so the sales of Enteral Nutrition in China will maintain a growing trend.

Topics Covered:
-The impact of COVID-19 on China’s Enteral Nutrition market
– Sales value of China’s Enteral Nutrition 2016-2020
– Competitive landscape of China’s Enteral Nutrition market
– Prices of Enteral Nutrition in China
– Prices of Enteral Nutrition in China by regions and manufacturers
– Analysis on factors affecting the development of China’s Enteral Nutrition market
– Prospect of China’s Enteral Nutrition market from 2021 to 2025

Additional information

Publisher

Date Published

Pages

Charts

Format

Table of Contents

1 Relevant Concepts of Enteral Nutrition
1.1 Indications for Enteral Nutrition
1.2 Development of Enteral Nutrition in China
1.3 Governmental Approval of Enteral Nutrition in China
1.4 The Impact of COVID-19 on Enteral Nutrition sales in China

2 Sales of Enteral Nutrition in China, 2016-2020
2.1 Sales Value of Enteral Nutrition
2.1.1 Overall Sales Value
2.1.2 Sales Value by Region
2.2 Sales Volume of Enteral Nutrition
2.2.1 Overall Sales Volume
2.2.2 Sales Volume by Region
2.3 Sales of Enteral Nutrition by Dosage Form in China, 2016-2020
2.3.1 Suspension
2.3.2 Oral Powder
2.3.3 Oral Emulsion

3 Analysis of Major Enteral Nutrition Manufacturers in China, 2016-2020
3.1 Analysis of Market Share of Major Enteral Nutrition Manufacturers
3.1.1 Investigation on Market Share by Sales Value
3.1.2 Investigation on Market Share by Sales volume
3.2 Niudi Xiya Pharmaceutical (Wuxi) Co.,Ltd.
3.2.1 Enterprise Profile
3.2.2 Sales of PEPTISON (Niudi Xiya Pharmaceutical (Wuxi) Co.,ltd.’s Enteral Nutrition) in China
3.3 Fresenius Kabi Deutschland GmbH
3.3.1 Enterprise Profile
3.3.2 Sales of FRESUBIN (Fresenius Kabi Deutschland GmbH’s Enteral Nutrition) in China
3.4 Fresenius Kabi Huarui Pharmaceutical Co., Ltd.
3.4.1 Enterprise Profile
3.4.2 Sales of FRESUBIN DIABETES, FRESUBIN 750MCT, Ruineng (Fresenius Kabi Huarui Pharmaceutical Co., Ltd.’s Enteral Nutrition) in China
3.5 Abbott Laboratories BV
3.5.1 Enterprise Profile
3.5.2 Sales of JEVITY (Abbott Laboratories BV’s Enteral Nutrition) in China
3.6 Milupa GmnH & Co KG
3.6.1 Enterprise Profile
3.6.2 Sales of NUTRISON (Milupa GmnH & Co KG’s Enteral Nutrition) in China

4 Prices of Enteral Nutrition for Different Manufacturers in China, 2020-2021
4.1 Niudi Xiya Pharmaceutical (Wuxi) Co.,ltd. (PEPTISON)
4.2 Fresenius Kabi Deutschland GmbH (FRESUBIN)
4.3 Fresenius Kabi Huarui Pharmaceutical Co., Ltd. (FRESUBIN DIABETES, FRESUBIN 750MCT, Ruineng)
4.4 Abbott Laboratories BV (JEVITY)
4.5 Milupa GmnH & Co KG(NUTRISON)

5 Prospect of Chinese Enteral Nutrition Market, 2021-2025
5.1 Influential Factors of Chinese Enteral Nutrition Market Development
5.1.1 The Impact of COVID-19 on Chinese Enteral Nutrition Market
5.1.2 Market Drivers and Opportunities
5.1.3 Market Threats and Challenges
5.2 Forecast on Market Size
5.3 Forecast on Market Trend

List of Charts
Chart Patent Information About Enteral Nutrition Suspension Registration in China
Chart Patent Information About Enteral Nutrition Oral Powder Registration in China
Chart Patent Information About Enteral Nutrition Oral Emulsion Registration in China
Chart Sales Value of Enteral Nutrition Suspension over the World
Chart Sales Value of Enteral Nutrition Oral Powder over the World
Chart Sales Value of Enteral Nutrition Oral Emulsion over the World
Chart Sales Value of Enteral Nutrition Suspension in China, 2016-2020
Chart Sales Value of Enteral Nutrition Oral Powder in China, 2016-2020
Chart Sales Value of Enteral Nutrition Oral Emulsion in China, 2016-2020
Chart Sales Value of Enteral Nutrition Suspension in China by Region, 2016-2020
Chart Sales Value of Enteral Nutrition Oral Powder in China by Region, 2016-2020
Chart Sales Value of Enteral Nutrition Oral Emulsion in China by Region, 2016-2020
Chart Sales Volume of Enteral Nutrition Suspension in China, 2016-2020
Chart Sales Volume of Enteral Nutrition Oral Powder in China, 2016-2020
Chart Sales Volume of Enteral Nutrition Oral Emulsion in China, 2016-2020
Chart Sales Volume of Enteral Nutrition Suspension in China by Region, 2016-2020
Chart Sales Volume of Enteral Nutrition Oral Powder in China by Region, 2016-2020
Chart Sales Volume of Enteral Nutrition Oral Emulsion in China by Region, 2016-2020
Chart Market Share by Sales Value of Top Enteral Nutrition Suspension Manufacturers in China, 2016-2020
Chart Market Share by Sales Value of Top Enteral Nutrition Oral Powder Manufacturers in China, 2016-2020
Chart Market Share by Sales Value of Top Enteral Nutrition Oral Emulsion Manufacturers in China, 2016-2020
Chart Sales Value and Volume of PEPTISON in China, 2016-2020
Chart Sales Value and Volume of FRESUBIN in China, 2016-2020
Chart Sales Value and Volume of FRESUBIN DIABETES, FRESUBIN 750MCT, Ruineng in China, 2016-2020
Chart Sales Value and Volume of JEVITY in China, 2016-2020
Chart Sales Value and Volume of NUTRISON in China, 2016-2020
Chart Referential Prices of PEPTISON in China by Region, 2020-2021
Chart Referential Prices of FRESUBIN in China by Region, 2020-2021
Chart Referential Prices of FRESUBIN DIABETES, FRESUBIN 750MCT, Ruineng in China by Region, 2020-2021
Chart Referential Prices of JEVITY in China by Region, 2020-2021
Chart Referential Prices of NUTRISON in China by Region, 2020-2021
Chart Forecast on Sales Value of Enteral Nutrition Suspension in China, 2021-2025
Chart Forecast on Sales Value of Enteral Nutrition Oral Powder in China, 2021-2025
Chart Forecast on Sales Value of Enteral Nutrition Oral Emulsion in China, 2021-2025
Chart Forecast on Sales Volume of Enteral Nutrition Suspension in China, 2021-2025
Chart Forecast on Sales Volume of Enteral Nutrition Oral Powder in China, 2021-2025
Chart Forecast on Sales Volume of Enteral Nutrition Oral Emulsion in China, 2021-2025

RSS
Follow by Email